September 20 (SeeNews) - Kiril Domuschiev, president and CEO of Bulgarian animal and human health and nutraceuticals company Huvepharma, plans to invest $5 million (4.67 million euro) through his family's fund Domuschiev Impact to establish a global anti-malaria centre.